Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT StudyGELENBERG, Alan J; DUNNER, David L; ROTHSCHILD, Anthony J et al.The Journal of nervous and mental disease. 2013, Vol 201, Num 4, pp 266-273, issn 0022-3018, 8 p.Article

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression : a secondary analysis of data from the PREVENT studyKORNSTEIN, Susan G; KOCSIS, James H; KELLER, Martin et al.International clinical psychopharmacology. 2008, Vol 23, Num 6, pp 357-363, issn 0268-1315, 7 p.Article

Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: Results from the PREVENT studyTHASE, Michael E; GELENBERG, Alan; KORNSTEIN, Susan G et al.Journal of psychiatric research. 2011, Vol 45, Num 3, pp 412-420, issn 0022-3956, 9 p.Article

Treatment of posttraumatic stress disorder with venlafaxine extended release : A 6-month randomized controlled trialDAVIDSON, Jonathan; BALDWIN, David; STEIN, Dan J et al.Archives of general psychiatry. 2006, Vol 63, Num 10, pp 1158-1165, issn 0003-990X, 8 p.Article

Correlation between patient and clinician assessments of depression severity in the PREVENT studyDUNLOP, Boadie W; LI, Thomas; KORNSTEIN, Susan G et al.Psychiatry research (Print). 2010, Vol 177, Num 1-2, pp 177-183, issn 0165-1781, 7 p.Article

An Assessment of Drug-Drug Interactions : The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy SubjectsPATRONEVA, Albena; CONNOLLY, Sandra M; FATATO, Penny et al.Drug metabolism and disposition. 2008, Vol 36, Num 12, pp 2484-2491, issn 0090-9556, 8 p.Article

A Pooled Analysis of Gender and Trauma-Type Effects on Responsiveness to Treatment of PTSD With Venlafaxine Extended Release or PlaceboROTHBAUM, Barbara O; DAVIDSON, Jonathan R. T; STEIN, Dan J et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 10, issn 0160-6689, 1529-1539 [11 p.]Article

Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placeboDAVIDSON, Jonathan; STEIN, Dan J; ROTHBAUM, Barbara O et al.Journal of psychopharmacology (Oxford). 2012, Vol 26, Num 6, pp 778-783, issn 0269-8811, 6 p.Article

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorderDUNLOP, Boadie W; LI, Thomas; KORNSTEIN, Susan G et al.Journal of psychiatric research. 2011, Vol 45, Num 1, pp 96-103, issn 0022-3956, 8 p.Article

Effects of venlafaxine extended release on resilience in posttraumatic stress disorder : an item analysis of the Connor-Davidson Resilience ScaleDAVIDSON, Jonathan; BALDWIN, David S; STEIN, Dan J et al.International clinical psychopharmacology. 2008, Vol 23, Num 5, pp 299-303, issn 0268-1315, 5 p.Article

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study : Outcomes from the Acute and Continuation PhasesKELLER, Martin B; TRIVEDI, Madhukar H; DUNLOP, Boadie W et al.Biological psychiatry (1969). 2007, Vol 62, Num 12, pp 1371-1379, issn 0006-3223, 9 p.Article